Rhizopus is a genus of fast-growing mold found on every continent, familiar to most people as the fuzzy black or gray growth that appears on stale bread, overripe fruit, or forgotten leftovers. Despite its humble reputation as a kitchen nuisance, the genus is scientifically fascinating and medically significant. Several Rhizopus species are leading causes of mucormycosis, a rare but frequently fatal fungal infection, while other species are deliberately cultivated to make fermented foods like tempeh. Understanding Rhizopus means understanding a mold that sits at a surprising intersection of human health, agriculture, food science, and industrial chemistry.
What Rhizopus Looks Like and How It Grows
Rhizopus belongs to the Mucoromycota, an ancient lineage of fungi that diverged from more familiar molds like Aspergillus and Penicillium hundreds of millions of years ago. Species in the genus share a few recognizable features: they produce root-like structures called rhizoids that anchor the fungus to whatever surface it is colonizing, and they send up tall stalks called sporangiophores topped by round spore sacs. When those sacs darken and burst, they release thousands of sporangiospores into the air. This is why bread mold seems to “appear overnight” in warm, humid kitchens: the spores are already everywhere, and germination can begin within hours once conditions are right.
The genus contains roughly a dozen recognized species, though species boundaries have shifted as researchers apply modern genomic tools. The two species most relevant to human disease are Rhizopus arrhizus (also known by its older name Rhizopus oryzae) and Rhizopus microsporus. In agriculture, the species that matters most is Rhizopus stolonifer, the classic bread mold and a major cause of soft rot in harvested fruit. And in food production, Rhizopus oligosporus is the workhorse species behind tempeh fermentation.
An Unusually Large Genome
One of the more striking discoveries about Rhizopus came from sequencing the genome of R. arrhizus. Researchers found clear evidence that the entire genome had been duplicated at some point in the lineage’s past, a rare event in fungi. The duplication left behind pairs of genes arranged in the same order on different chromosomes, and many of those duplicated genes are still functional. The duplicated gene families include those involved in respiratory energy production, protein recycling, and cell signaling, along with expanded families of secreted enzymes known to act as virulence factors in fungal infections.
1PubMed Central. Genomic Analysis of the Basal Lineage Fungus Rhizopus oryzae Reveals a Whole-Genome DuplicationGenome sizes vary across the genus, with some species carrying genomes of about 38 to 48 megabases following what appear to be incomplete or independent duplication events in different lineages. This size variation, mapped onto the evolutionary tree of the genus, suggests that genome expansion happened more than once and is not limited to R. arrhizus.
2G3 Genes|Genomes|Genetics. Phylogenetic and Phylogenomic Definition of Rhizopus SpeciesHow Rhizopus Causes Mucormycosis
Mucormycosis is the umbrella term for infections caused by molds in the order Mucorales, and Rhizopus arrhizus is the single most common culprit. The infection typically affects people whose immune defenses are compromised: those with poorly controlled diabetes (especially when blood chemistry shifts into ketoacidosis), organ transplant recipients on immunosuppressive drugs, cancer patients with very low white blood cell counts, and people on prolonged high-dose corticosteroids. Mucormycosis is uncommon, but when it strikes, mortality rates are high, often exceeding 50 percent even with treatment.
The hallmark of mucormycosis is angioinvasion, meaning the fungus invades blood vessel walls. This causes blood clots to form inside the vessels and starves the surrounding tissue of oxygen, producing the characteristic blackened, necrotic tissue that clinicians look for. Research on how R. arrhizus attaches to and damages the cells lining blood vessels has confirmed that these endothelial cell interactions are central to the disease process.
3PubMed Central. Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitroThe molecular machinery behind this invasion has come into sharper focus in recent years. On the fungal side, the key players are a family of surface proteins called CotH (spore coat protein homologs). On the human side, the receptor these proteins latch onto is GRP78, a stress-response protein that sits on the surface of endothelial cells in higher-than-normal amounts when the body is under metabolic stress. When CotH proteins, particularly CotH3 and CotH2, bind to GRP78, they enable the fungal spore to invade the host cell. Experiments showed that engineering a completely different yeast to express CotH gave it the ability to invade human cells, while Rhizopus strains with reduced CotH expression lost much of their invasive capacity.
4PubMed Central. CotH3 mediates fungal invasion of host cells during mucormycosisBeyond CotH, Rhizopus also deploys a toxin called mucoricin, which is structurally similar to ricin and damages the lining of blood vessels, further undermining tissue integrity.
5PubMed Central. Molecular Mechanisms of Mucormycosis Pathogenesis: Host-Pathogen Interactions and Immune EvasionIron, Diabetes, and the COVID-19 Surge
Iron is essential for Rhizopus to germinate and grow inside the body, and the fungus has evolved aggressive strategies to get it. During infection, it must compete against the host’s own iron-binding proteins, which normally keep free iron levels extremely low as a defense against pathogens.
6PubMed Central. Iron acquisition strategies in pathogenic fungi One pathway involves specialized surface receptors, Fob1 and Fob2, that can grab iron from a surprising source: deferoxamine, a drug used to treat iron overload in patients with chronic kidney disease. Deferoxamine binds iron, but Rhizopus can use it as an iron delivery vehicle, stripping the iron free via a reductive uptake system. Strains with reduced Fob1 and Fob2 expression lost much of this ability and were less virulent in mice treated with deferoxamine.
7PLoS Pathogens. Fob1 and Fob2 Proteins Are Virulence Determinants of Rhizopus oryzae via Facilitating Iron Uptake from FerrioxamineThis explains a long-standing clinical observation: patients on deferoxamine for iron chelation had a dramatically elevated risk of mucormycosis. Two alternative iron chelators, deferiprone and deferasirox, do not act as siderophores for the fungus and actually kill Mucorales in laboratory conditions.
8PubMed Central. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatmentDiabetic ketoacidosis (DKA) is the single biggest predisposing condition for mucormycosis, and the mechanism ties back to both iron and the CotH-GRP78 invasion pathway. The acidic metabolic byproducts of ketoacidosis directly increase expression of both GRP78 on host cells and CotH on the fungal surface, making invasion more likely. At the same time, the acidic blood chemistry weakens the ability of transferrin, the body’s main iron-transport protein, to hold onto its iron, flooding the environment with free iron that Rhizopus can exploit. In mouse models, correcting the acidosis with bicarbonate and simultaneously chelating iron completely protected endothelial cells from Rhizopus invasion.
9JCI Insight. Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosisThe COVID-19 pandemic brought mucormycosis into the headlines, especially in India, where an unprecedented wave of cases hit during the severe second surge in early 2021. The likely explanation was a convergence of risk factors: a high background rate of poorly controlled or undiagnosed diabetes in the population, COVID-19-related immune dysfunction, and widespread use of systemic corticosteroids (which suppress immune responses and raise blood sugar).
10Clinical Infectious Diseases. Coronavirus Disease 2019–Associated Mucormycosis: Risk Factors and Mechanisms of Disease Case reports documented patients with uncontrolled diabetes who developed rhinosinusitis mucormycosis within days of completing corticosteroid treatment for COVID-19, underscoring how quickly the infection can take hold when multiple risk factors align.11PubMed Central. Case Report: COVID-19-associated Rhinosinusitis Mucormycosis Caused by Rhizopus arrhizus: A Rare but Potentially Fatal Infection Occurring After Treatment with Corticosteroids
Treatment and the Drug Resistance Problem
The standard first-line treatment for mucormycosis is amphotericin B, typically in its liposomal formulation, which is somewhat less toxic to the kidneys. Treatment almost always requires early, aggressive surgical removal of infected tissue alongside antifungal therapy; drugs alone are often insufficient because the blood-vessel invasion and tissue death mean the drug cannot reliably reach the infected site.
12PubMed. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment OptionsRhizopus and related Mucorales are intrinsically resistant to the most commonly prescribed azole antifungals, fluconazole and voriconazole. This is a clinically dangerous gap, because voriconazole is a go-to drug for other invasive mold infections like aspergillosis. Patients empirically started on voriconazole for a suspected mold infection when the actual cause is Rhizopus can deteriorate rapidly. The molecular basis for this resistance involves differences in the fungal drug target that prevent short-tailed azole molecules from binding effectively, whereas the longer-tailed azole posaconazole retains activity.
13PubMed Central. The molecular basis of intrinsic resistance to azoles in Rhizopus arrhizusA newer azole, isavuconazole, has shown promise. In mouse models of pulmonary mucormycosis, high-dose isavuconazole was as effective as liposomal amphotericin B at prolonging survival and reducing fungal burden.
14PubMed Central. Isavuconazole therapy protects immunosuppressed mice from mucormycosis Even more encouraging, combining the two drugs proved synergistic in neutropenic mice infected with R. delemar: roughly 80 percent of mice receiving the combination survived, compared with about 50 percent on either drug alone and just 5 percent on placebo.15Journal of Antimicrobial Chemotherapy. Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis
Another therapeutic frontier targets the CotH-GRP78 invasion pathway. Antibodies against CotH3 protected mice from mucormycosis by blocking fungal invasion and also by helping immune cells engulf the spores more effectively.
16PubMed Central. Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis This kind of immunotherapy is still in early stages, but CotH proteins exist across the Mucorales and are absent from the human genome, making them an attractive drug target.
Faster Diagnosis With Molecular Tools
One reason mucormycosis kills so often is that diagnosis tends to be slow. Traditional methods rely on seeing the characteristic wide, ribbon-like fungal filaments in tissue biopsies or growing the organism in culture, both of which take time and lack sensitivity. Molecular approaches are changing this. Multiplex PCR assays targeting the ribosomal DNA regions of Rhizopus species have shown the ability to detect and identify pathogenic Rhizopus directly from clinical samples, including paraffin-embedded tissue sections and even serum.
17PubMed. Genetic identification and detection of human pathogenic Rhizopus species, a major mucormycosis agent, by multiplex PCR based on internal transcribed spacer region of rRNA gene Newer real-time PCR workflows can detect Mucorales broadly and then differentiate R. arrhizus, R. microsporus, and Mucor species, cutting turnaround time and cost compared with commercial kits.18PubMed Central. Development and evaluation of a Pan-Mucorales Real-time PCR and a multiplex Real-time PCR for detection and identification of Rhizopus arrhizus, Rhizopus microsporus, and Mucor spp. in clinical specimens
Rhizopus as a Crop Pathogen
Outside the clinic, the Rhizopus species that causes the most economic damage is R. stolonifer, the soft-rot pathogen of harvested fruits. Strawberries, peaches, nectarines, plums, and sweet potatoes are all vulnerable. The fungus behaves as a necrotroph, killing plant tissue and then feeding on the remains. Researchers profiling its gene expression during infection identified a toolkit of about 33 oxidoreductases, 7 proteases, and 4 cell-wall-degrading enzymes that it deploys to break down and liquefy host tissue.
19PubMed. Rhizopus stolonifer Exhibits Necrotrophic Behavior when Causing Soft Rot in Ripe FruitR. stolonifer was long assumed to require a wound on the fruit surface to gain entry, but research on stone fruits showed the fungus can penetrate intact skin by producing esterase enzymes capable of breaking down the waxy cutin layer. Blocking those esterases with a chemical inhibitor prevented rot development in peaches.
20Plant Pathology. Direct penetration of Rhizopus stolonifer into stone fruits causing rhizopus rot This matters for post-harvest handling because it means careful handling alone, while important, is not a complete defense.
Controlling Rhizopus soft rot without synthetic fungicides is a growing area of research. Essential oils have shown genuine activity. Lemongrass oil at moderate concentrations reduced rot incidence and severity in peaches by about 70 percent, and combining it with calcium chloride was even more effective.
21Scientia Horticulturae. Evaluation of alternative means to control postharvest Rhizopus rot of peaches Similarly, thymol-rich essential oil from Lippia sidoides applied as a carboxymethylcellulose coating reduced disease severity on strawberries, and electron microscopy confirmed the oil damaged the fungal cell wall.
22PubMed. Control of Rhizopus stolonifer in strawberries by the combination of essential oil with carboxymethylcelluloseTempeh and the Beneficial Side of Rhizopus
Not all Rhizopus species are villains. Rhizopus oligosporus is the fungus behind tempeh, the Indonesian fermented soybean product that has gone global as a plant-protein staple. During tempeh fermentation, R. oligosporus knits soybeans together with its dense white mycelium while producing enzymes that break down proteins and starches, making nutrients more bioavailable and giving tempeh its characteristic firm, sliceable texture.
23PubMed Central. Tempeh-type fermentation kinetics of tarwi (Lupinus mutabilis) and red quinoa (Chenopodium quinoa) with Rhizopus oligosporus: effects on texture, metabolite profile and nutritional potentialResearchers are now applying the tempeh process to other legumes and grains beyond soybeans. When the method was used on African yambean seeds, it increased protein and starch content while nearly eliminating anti-nutritional compounds that normally make the bean difficult to eat safely. A modified version of the process also removed cyanogenic glycosides that standard cooking could not fully eliminate, making it a safer and more energy-efficient preparation method.
24Journal of the Science of Food and Agriculture. Nutritional value of African yambean (Sphenostylis stenocarpa, L): improvement by solid substrate fermentation using the tempeh fungus Rhizopus oligosporus Work on Andean crops like tarwi (a lupin) and red quinoa has followed the same logic, using R. oligosporus fermentation to modify texture and nutritional profiles of underutilized crops for sustainable food development.25PubMed Central. Tempeh-type fermentation kinetics of tarwi (Lupinus mutabilis) and red quinoa (Chenopodium quinoa) with Rhizopus oligosporus: effects on texture, metabolite profile and nutritional potential
Industrial Uses and Bioremediation
Rhizopus species have carved out roles in industrial biotechnology that have nothing to do with food or disease. R. oryzae produces a lipase enzyme with properties that make it attractive for use in energy, food processing, and pharmaceuticals: it selectively acts on specific positions of fat molecules and remains stable in organic solvents, which is unusual for biological enzymes.
26MDPI Catalysts. Rhizopus oryzae Lipase, a Promising Industrial Enzyme: Biochemical Characteristics, Production and Biocatalytic Applications The same species can produce fumaric acid, a chemical building block used in resins and food additives, from agricultural waste like corncob hydrolysates, which makes it interesting for green chemistry applications.27PubMed. Production of Fumaric Acid by Bioconversion of Corncob Hydrolytes Using an Improved Rhizopus oryzae Strain
On the environmental side, dead Rhizopus biomass turns out to be an effective sponge for heavy metals dissolved in water. The cell walls of fungi like R. arrhizus have a natural affinity for metal ions including zinc, cadmium, nickel, lead, and chromium, making them candidates for biosorption systems that clean contaminated industrial wastewater.
28FEMS Microbiology Reviews. Improvement of heavy metal biosorption by mycelial dead biomasses (Rhizopus arrhizus, Mucor miehei and Penicillium chrysogenum): pH control and cationic activation More recent work has zeroed in on hexavalent chromium, a particularly toxic pollutant. Rhizopus biomass pretreated with sodium chloride removed up to 99 percent of hexavalent chromium from test solutions under optimized conditions.29PubMed. Cr(VI) adsorption from aqueous solution by fungal bioremediation based using Rhizopus sp
The Bacteria Living Inside the Fungus
Perhaps the most surprising chapter in Rhizopus biology involves a discovery about R. microsporus, a species known to produce rhizoxin, a potent toxin that damages rice seedlings and is also being studied for its antitumor properties. In 2005, researchers showed that the fungus does not actually make rhizoxin itself. The toxin is produced by bacteria of the genus Burkholderia living inside the fungal cells as endosymbionts.
30Nature. Pathogenic fungus harbours endosymbiotic bacteria for toxin production Curing the fungus of its bacterial passengers eliminates toxin production entirely. This was one of the first clear demonstrations that a fungal “toxin” could actually be a bacterial product, and it opened up a whole field of research into fungal-bacterial symbioses. The relationship appears to be mutually beneficial: the bacteria get a protected intracellular habitat, and the fungus gets a chemical weapon. For anyone trying to control rhizoxin toxicity in agricultural settings, the practical implication is that the target may need to be the bacterium, not the fungus.